818 related articles for article (PubMed ID: 23916482)
1. Differential regulation of Bdnf expression in cortical neurons by class-selective histone deacetylase inhibitors.
Koppel I; Timmusk T
Neuropharmacology; 2013 Dec; 75():106-15. PubMed ID: 23916482
[TBL] [Abstract][Full Text] [Related]
2. Inhibitors of histone deacetylases in class I and class II suppress human osteoclasts in vitro.
Cantley MD; Fairlie DP; Bartold PM; Rainsford KD; Le GT; Lucke AJ; Holding CA; Haynes DR
J Cell Physiol; 2011 Dec; 226(12):3233-41. PubMed ID: 21344383
[TBL] [Abstract][Full Text] [Related]
3. MC1568 Inhibits Thimerosal-Induced Apoptotic Cell Death by Preventing HDAC4 Up-Regulation in Neuronal Cells and in Rat Prefrontal Cortex.
Guida N; Laudati G; Mascolo L; Cuomo O; Anzilotti S; Sirabella R; Santopaolo M; Galgani M; Montuori P; Di Renzo G; Canzoniero LM; Formisano L
Toxicol Sci; 2016 Dec; 154(2):227-240. PubMed ID: 27660204
[TBL] [Abstract][Full Text] [Related]
4. Class I histone deacetylase-mediated repression of the proximal promoter of the activity-regulated cytoskeleton-associated protein gene regulates its response to brain-derived neurotrophic factor.
Fukuchi M; Nakashima F; Tabuchi A; Shimotori M; Tatsumi S; Okuno H; Bito H; Tsuda M
J Biol Chem; 2015 Mar; 290(11):6825-36. PubMed ID: 25623071
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of class IIa histone deacetylase activity by gallic acid, sulforaphane, TMP269, and panobinostat.
Choi SY; Kee HJ; Jin L; Ryu Y; Sun S; Kim GR; Jeong MH
Biomed Pharmacother; 2018 May; 101():145-154. PubMed ID: 29482060
[TBL] [Abstract][Full Text] [Related]
6. Effects of histone deacetylase inhibitor Trichostatin A on epigenetic changes and transcriptional activation of Bdnf promoter 1 by rat hippocampal neurons.
Tian F; Marini AM; Lipsky RH
Ann N Y Acad Sci; 2010 Jun; 1199():186-93. PubMed ID: 20633124
[TBL] [Abstract][Full Text] [Related]
7. The mood stabilizers lithium and valproate selectively activate the promoter IV of brain-derived neurotrophic factor in neurons.
Yasuda S; Liang MH; Marinova Z; Yahyavi A; Chuang DM
Mol Psychiatry; 2009 Jan; 14(1):51-9. PubMed ID: 17925795
[TBL] [Abstract][Full Text] [Related]
8. Enhancement of BDNF Expression and Memory by HDAC Inhibition Requires BET Bromodomain Reader Proteins.
Sartor GC; Malvezzi AM; Kumar A; Andrade NS; Wiedner HJ; Vilca SJ; Janczura KJ; Bagheri A; Al-Ali H; Powell SK; Brown PT; Volmar CH; Foster TC; Zeier Z; Wahlestedt C
J Neurosci; 2019 Jan; 39(4):612-626. PubMed ID: 30504275
[TBL] [Abstract][Full Text] [Related]
9. Selective inhibition of class I but not class IIb histone deacetylases exerts cardiac protection from ischemia reperfusion.
Aune SE; Herr DJ; Mani SK; Menick DR
J Mol Cell Cardiol; 2014 Jul; 72():138-45. PubMed ID: 24632412
[TBL] [Abstract][Full Text] [Related]
10. Class IIa histone deacetylases affect neuronal remodeling and functional outcome after stroke.
Kassis H; Shehadah A; Li C; Zhang Y; Cui Y; Roberts C; Sadry N; Liu X; Chopp M; Zhang ZG
Neurochem Int; 2016 Jun; 96():24-31. PubMed ID: 27103167
[TBL] [Abstract][Full Text] [Related]
11. HDAC4 and HDAC5 form a complex with DREAM that epigenetically down-regulates NCX3 gene and its pharmacological inhibition reduces neuronal stroke damage.
Formisano L; Laudati G; Guida N; Mascolo L; Serani A; Cuomo O; Cantile M; Boscia F; Molinaro P; Anzilotti S; Pizzorusso V; Di Renzo G; Pignataro G; Annunziato L
J Cereb Blood Flow Metab; 2020 Oct; 40(10):2081-2097. PubMed ID: 31696766
[TBL] [Abstract][Full Text] [Related]
12. SMRT-mediated co-shuttling enables export of class IIa HDACs independent of their CaM kinase phosphorylation sites.
Soriano FX; Chawla S; Skehel P; Hardingham GE
J Neurochem; 2013 Jan; 124(1):26-35. PubMed ID: 23083128
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of histone deacetylation by trichostatin A intensifies the transcriptions of neuronal c-fos and c-jun genes after kainate stimulation.
Sng JC; Taniura H; Yoneda Y
Neurosci Lett; 2005 Oct; 386(3):150-5. PubMed ID: 16002216
[TBL] [Abstract][Full Text] [Related]
14. Class I histone deacetylase inhibition modulates metalloproteinase expression and blocks cytokine-induced cartilage degradation.
Culley KL; Hui W; Barter MJ; Davidson RK; Swingler TE; Destrument AP; Scott JL; Donell ST; Fenwick S; Rowan AD; Young DA; Clark IM
Arthritis Rheum; 2013 Jul; 65(7):1822-30. PubMed ID: 23575963
[TBL] [Abstract][Full Text] [Related]
15. Inhibitors of histone deacetylases enhance neurotoxicity of DNA damage.
Vashishta A; Hetman M
Neuromolecular Med; 2014 Dec; 16(4):727-41. PubMed ID: 25063076
[TBL] [Abstract][Full Text] [Related]
16. MS-275 inhibits aroclor 1254-induced SH-SY5Y neuronal cell toxicity by preventing the formation of the HDAC3/REST complex on the synapsin-1 promoter.
Formisano L; Guida N; Laudati G; Mascolo L; Di Renzo G; Canzoniero LM
J Pharmacol Exp Ther; 2015 Feb; 352(2):236-43. PubMed ID: 25467131
[TBL] [Abstract][Full Text] [Related]
17. Persistent BDNF exon I-IX mRNA expression following the withdrawal of neuronal activity in neurons.
Hara D; Miyashita T; Fukuchi M; Suzuki H; Azuma Y; Tabuchi A; Tsuda M
Biochem Biophys Res Commun; 2009 Dec; 390(3):648-53. PubMed ID: 19818730
[TBL] [Abstract][Full Text] [Related]
18. Class II histone deacetylases require P/Q-type Ca
Urbano FJ; Bisagno V; Mahaffey S; Lee SH; Garcia-Rill E
Sci Rep; 2018 Sep; 8(1):13156. PubMed ID: 30177751
[TBL] [Abstract][Full Text] [Related]
19. S18986: a positive modulator of AMPA-receptors enhances (S)-AMPA-mediated BDNF mRNA and protein expression in rat primary cortical neuronal cultures.
Lockhart BP; Rodriguez M; Mourlevat S; Peron P; Catesson S; Villain N; Galizzi JP; Boutin JA; Lestage P
Eur J Pharmacol; 2007 Apr; 561(1-3):23-31. PubMed ID: 17331496
[TBL] [Abstract][Full Text] [Related]
20. Ketamine induces brain-derived neurotrophic factor expression via phosphorylation of histone deacetylase 5 in rats.
Choi M; Lee SH; Park MH; Kim YS; Son H
Biochem Biophys Res Commun; 2017 Aug; 489(4):420-425. PubMed ID: 28577999
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
